Mapreg

MAPREG is a damaged neuronal function with drugs that specifically stimulate the neuronal microtubules.

Operating in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), Mapreg operates.

Within the biotechnology space, the company focuses on its core offering rather than a broad product line.

The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).

It is recorded at the Private company stage.

Sector	Biotechnology
Headquarters	European Union (EU), Europe, Middle East, and Africa (EMEA)
Stage	Private company

Website: www.mapreg.com

Browse related

Contact details and direct channels are available to signed-in members.
Create a free account